Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Fiona Powrie, Director of the Kennedy Institute will be speaking at The Times Cheltenham Science Festival, this Tuesday 2 June.

The Director of the Kennedy Institute, Professor Fiona Powrie will be speaking at The Times Cheltenham Science Festival, this June.

The event Our friendly bacteria will look at the microbiome - the population of more than 100 trillion microorganisms that live in our gut, mouth, skin and elsewhere in our bodies! - and how it links to our immune system. Immunologist Fiona Powrie will be joined by microbiologist Lindsay Hall and event chair Adam Hart; together they will explore our body's vital bacterial ecosystem and what happens when things go wrong: from allergies to cancer.

Are you around Cheltenham on Tuesday 2 June 14:30? Then join us for a lively discussion on how the immune system is keeping our teeth from falling out!

Get your ticket here

Similar stories

The Kennedy Institute Student Symposium returns for its 5th year

A two-day student symposium returned to the Kennedy Institute bringing together students and peers from across the department to discuss their latest research.

Researchers from the Kennedy Institute awarded MRC funding

Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Major ERC funding awarded to Professor Michael Dustin

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

Drug may boost vaccine responses in older adults

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships

Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.